{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:45:22Z","timestamp":1780044322653,"version":"3.53.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jacl.2018.05.021","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T04:18:22Z","timestamp":1529554702000},"page":"1260-1266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Combination therapy of omega-3 fatty acids and acipimox for children with hypertriglyceridemia and acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"12","author":[{"given":"C.","family":"Salvador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Entenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Niederwanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Crazzolara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kropshofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2018.05.021_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.118.1.99","article-title":"Evidence that the L-asparaginase of guinea pig serum is responsible for its antilymphoma effects. I. Properties of the L-asparaginase of guinea pig serum in relation to those of the antilymphoma substance","volume":"118","author":"Broome","year":"1963","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.jacl.2018.05.021_bib2","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jama.1967.03130220070012","article-title":"L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia","volume":"202","author":"Hill","year":"1967","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jacl.2018.05.021_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM198609113151101","article-title":"Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia","volume":"315","author":"Clavell","year":"1986","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacl.2018.05.021_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0609.1992.tb00032.x","article-title":"Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA group","volume":"49","author":"Gugliotta","year":"1992","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.jacl.2018.05.021_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V83.2.386.386","article-title":"Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiency","volume":"83","author":"Mitchell","year":"1994","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jacl.2018.05.021_bib6","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood.V89.6.1886","article-title":"Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia","volume":"89","author":"Parsons","year":"1997","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jacl.2018.05.021_bib7","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/sj.leu.2400703","article-title":"Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity","volume":"11","author":"Hoogerbrugge","year":"1997","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.jacl.2018.05.021_bib8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1161\/01.ATV.11.3.760","article-title":"Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats","volume":"11","author":"Staels","year":"1991","journal-title":"Arterioscler Thromb"},{"issue":"3","key":"10.1016\/j.jacl.2018.05.021_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem-57-3-619","article-title":"Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome","volume":"57","author":"Taskinen","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jacl.2018.05.021_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF00442614","article-title":"The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemia","volume":"147","author":"Cremer","year":"1988","journal-title":"Eur J Pediatr"},{"issue":"12","key":"10.1016\/j.jacl.2018.05.021_bib11","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1002\/1097-0142(19941215)74:12<3234::AID-CNCR2820741224>3.0.CO;2-1","article-title":"Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase","volume":"74","author":"Steinherz","year":"1994","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jacl.2018.05.021_bib12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/pbc.20986","article-title":"Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis","volume":"50","author":"Ridola","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.jacl.2018.05.021_bib13","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/00007611-199909000-00013","article-title":"Drug-induced hypertriglyceridemia with and without pancreatitis","volume":"92","author":"Keung","year":"1999","journal-title":"South Med J"},{"issue":"2","key":"10.1016\/j.jacl.2018.05.021_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1055\/s-2007-921455","article-title":"Cerebral sinus occlusion in a boy presenting with asparaginase-induced hypertriglyceridemia","volume":"219","author":"Dietel","year":"2007","journal-title":"Klin Padiatr"},{"issue":"6","key":"10.1016\/j.jacl.2018.05.021_bib15","first-page":"775","article-title":"Hypertriglyceridemia and peripheral neuropathy in neurologically asymptomatic patients","volume":"26","author":"Kassem","year":"2005","journal-title":"Neuro Endocrinol Lett"},{"issue":"2","key":"10.1016\/j.jacl.2018.05.021_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/mpo.10067","article-title":"Plasmapheresis as treatment for transient iatrogenic severe hyperlipidemia in a child with leukemia","volume":"41","author":"Kropshofer","year":"2003","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"10.1016\/j.jacl.2018.05.021_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0021-9150(01)00656-6","article-title":"Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity","volume":"161","author":"Rosenson","year":"2002","journal-title":"Atherosclerosis"},{"issue":"Suppl 5","key":"10.1016\/j.jacl.2018.05.021_bib18","first-page":"S213","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","year":"2011","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.jacl.2018.05.021_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1742-1241.2005.00419.x","article-title":"Hypertriglyceridaemia and malignancy","volume":"59","author":"Wijeratne","year":"2005","journal-title":"Int J Clin Pract"},{"issue":"5","key":"10.1016\/j.jacl.2018.05.021_bib20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(82)90543-5","article-title":"Plasma lipid alterations in leukemia and lymphoma","volume":"72","author":"Spiegel","year":"1982","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.jacl.2018.05.021_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0145-2126(83)90135-2","article-title":"Fluorescence polarization as a parameter of plasma lipids in patients with hematologic malignancies","volume":"7","author":"Spiegel","year":"1983","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.jacl.2018.05.021_bib22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0889-8553(21)00513-6","article-title":"Hyperlipidemic pancreatitis","volume":"19","author":"Toskes","year":"1990","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"10.1016\/j.jacl.2018.05.021_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00004836-200301000-00016","article-title":"Issues in hyperlipidemic pancreatitis","volume":"36","author":"Yadav","year":"2003","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.jacl.2018.05.021_bib24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/pbc.22305","article-title":"Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia","volume":"54","author":"Cohen","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.jacl.2018.05.021_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/pbc.23177","article-title":"Very high hypertriglyceridemia induced: is plasmapheresis needed?","volume":"57","author":"Berrueco","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1016\/j.jacl.2018.05.021_bib26","doi-asserted-by":"crossref","first-page":"962.e1-8","DOI":"10.1016\/j.amjmed.2009.03.030","article-title":"Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review","volume":"122","author":"Abourbih","year":"2009","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.jacl.2018.05.021_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/pbc.24108","article-title":"Successful management of extreme hypertriglyceridemia from pegaspargase with omega-3","volume":"59","author":"Bostrom","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.jacl.2018.05.021_bib28","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3109\/10428194.2011.647312","article-title":"Acarbose is an effective treatment for severe hypertriglyceridemia secondary to l-asparaginase and dexamethasone","volume":"53","author":"Tan","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.jacl.2018.05.021_bib29","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1097\/MPH.0b013e3181f46c22","article-title":"Insulin infusion to treat severe hypertriglyceridemia associated with pegaspargase therapy: a case report","volume":"33","author":"Lawson","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.jacl.2018.05.021_bib30","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3945\/ajcn.111.023887","article-title":"Lipoprotein subfractions and dietary intake of n-3 fatty acid: the genetics of coronary artery disease in Alaska natives study","volume":"95","author":"Annuzzi","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1016\/j.jacl.2018.05.021_bib31","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.2337\/db13-1130","article-title":"Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals","volume":"63","author":"Daniele","year":"2014","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.jacl.2018.05.021_bib32","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2337\/diab.41.11.1400","article-title":"Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects","volume":"41","author":"Fulcher","year":"1992","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.jacl.2018.05.021_bib33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-291X(03)00342-5","article-title":"Molecular identification of nicotinic acid receptor","volume":"303","author":"Soga","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.jacl.2018.05.021_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2796.1991.tb00466.x","article-title":"A comparison between nicotinic acid and acipimox in hypertriglyceridaemia\u2013effects on serum lipids, lipoproteins, glucose tolerance and tolerability","volume":"230","author":"Tornvall","year":"1991","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.jacl.2018.05.021_bib35","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.amjcard.2006.08.013","article-title":"Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients","volume":"99","author":"Harris","year":"2007","journal-title":"Am J Cardiol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418302587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418302587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T02:31:12Z","timestamp":1661481072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287418302587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1933287418302587"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2018.05.021","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy of omega-3 fatty acids and acipimox for children with hypertriglyceridemia and acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2018.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}